This content is machine translated New S3 Guideline Lung Cancer Improve prevention, diagnostics, therapy and aftercare Today, the treatment of lung cancer is much more differentiated and also more complicated than it was ten years ago. This is due not least to the great dynamism in…
View Post 2 min This content is machine translated Aspergillosis and lung function Hope for newly developed therapeutic options Aspergillus fumigatus is a common mold that is relatively harmless if you have a good immune response. However, in people whose immune system is severely weakened – for example, after…
View Post 5 min This content is machine translated Guideline recommendations 2022 Update on secondary prevention of ischemic stroke and TIA. This year, the German Society of Neurology (DGN) and the German Stroke Society (DSG) published the new S2k guideline ‘Secondary prevention of ischemic stroke and transient ischemic attack’. This contains…
View Post 5 min This content is machine translated Chronic prurigo Proven and new therapeutic approaches put to the test Nowadays, chronic prurigo is defined as a disease in its own right. Prurigo nodularis in particular is very distressing for those affected. Local therapies are not effective in all patients,…
View Post 7 min This content is machine translated Genitourinary cancers Effective therapy management up-to date “Shaping the future together” was the motto of this year’s urology congress. Because health care must evolve. It is not only colleagues in the field of urology who are in…
View Post 5 min This content is machine translated System therapy for psoriasis Targeted treatment with classical and new targets – where is the journey heading? Today, psoriasis is considered an inflammatory systemic disease in which proinflammatory cytokines play an important role. Several inflammatory circuits are involved in the pathogenesis of psoriasis. Cytokines of the IL-23…
View Post 6 min This content is machine translated Tumor Medicine Cancer medicine between innovation and care Inspirations, ideas and visions for the future were the focus of this year’s DKK. About 10,000 visitors exchanged information on the interfaces of tumor medicine, rare cancers and new diagnostic…
View Post 5 min This content is machine translated Multiple Myeloma (MM) BLENREP payable by health insurer in heavily pretreated refractory MM. Belantamab mafodotin (BLENREP) is the first and only BCMA*-targeted antibody-drug conjugate to be approved in Switzerland in June 2022, and has been reimbursable since November 2022 for the treatment of…
View Post 4 min This content is machine translated Psoriatic arthritis therapy Early detection is of high prognostic importance Since psoriatic arthritis often occurs years after the onset of skin psoriasis, dermatologic evaluation of incipient joint involvement is particularly important. Early detection of joint involvement has important therapeutic implications.…
View Post 9 min This content is machine translated Pain Assessment The basis for individual therapy Historically, neuropathic pain has been classified based on the underlying etiology. However, given the heterogeneity of pain mechanisms, other classification schemes may be more appropriate. In this case, the individual…
View Post 3 min This content is machine translated Wound Management Means and objects list (MiGeL) – important changes at a glance In Switzerland, means and objects that serve the treatment or examination of a disease and its consequences are among the compulsory benefits of compulsory health care insurance. The effectiveness, appropriateness…
